Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
ILA 38.4
(12.61%)
ILA 38.4
(12.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 43.53 Million ILS | 9.09% |
| 2022 | 39.9 Million ILS | -13.17% |
| 2021 | 45.95 Million ILS | -21.78% |
| 2020 | 58.75 Million ILS | 5.75% |
| 2019 | 55.55 Million ILS | 692.75% |
| 2018 | 7 Million ILS | 1048.85% |
| 2017 | 610 Thousand ILS | -8.68% |
| 2016 | 668 Thousand ILS | 128.77% |
| 2015 | 292 Thousand ILS | 256.1% |
| 2014 | 82 Thousand ILS | -44.97% |
| 2013 | 149 Thousand ILS | -94.81% |
| 2012 | 2.87 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 36.76 Million ILS | -15.54% |
| 2024 Q2 | 36.76 Million ILS | 0.0% |
| 2023 Q1 | 43.76 Million ILS | 9.68% |
| 2023 Q3 | 43.53 Million ILS | -0.54% |
| 2023 Q2 | 43.76 Million ILS | 0.0% |
| 2023 FY | 43.53 Million ILS | 9.09% |
| 2023 Q4 | 43.53 Million ILS | 0.0% |
| 2022 Q2 | 52.47 Million ILS | 0.0% |
| 2022 Q3 | 39.9 Million ILS | -23.96% |
| 2022 Q4 | 39.9 Million ILS | 0.0% |
| 2022 FY | 39.9 Million ILS | -13.17% |
| 2022 Q1 | 52.47 Million ILS | 14.18% |
| 2021 Q3 | 45.95 Million ILS | -15.27% |
| 2021 Q1 | 54.23 Million ILS | -7.69% |
| 2021 Q2 | 54.23 Million ILS | 0.0% |
| 2021 Q4 | 45.95 Million ILS | 0.0% |
| 2021 FY | 45.95 Million ILS | -21.78% |
| 2020 FY | 58.75 Million ILS | 5.75% |
| 2020 Q3 | 58.75 Million ILS | 10.7% |
| 2020 Q4 | 58.75 Million ILS | 0.0% |
| 2020 Q1 | 53.07 Million ILS | -4.46% |
| 2020 Q2 | 53.07 Million ILS | 0.0% |
| 2019 Q2 | 8.85 Million ILS | 0.0% |
| 2019 FY | 55.55 Million ILS | 692.75% |
| 2019 Q4 | 55.55 Million ILS | 0.0% |
| 2019 Q3 | 55.55 Million ILS | 527.26% |
| 2019 Q1 | 8.85 Million ILS | 26.38% |
| 2018 FY | 7 Million ILS | 1048.85% |
| 2018 Q2 | 865 Thousand ILS | 0.0% |
| 2018 Q1 | - ILS | -100.0% |
| 2018 Q3 | 7 Million ILS | 710.17% |
| 2018 Q4 | 7 Million ILS | 0.0% |
| 2017 Q2 | 201 Thousand ILS | 0.0% |
| 2017 Q4 | 610 Thousand ILS | 0.0% |
| 2017 FY | 610 Thousand ILS | -8.68% |
| 2016 Q2 | 75 Thousand ILS | -29.25% |
| 2016 Q3 | 664 Thousand ILS | 785.33% |
| 2016 Q1 | 106 Thousand ILS | -63.7% |
| 2016 FY | 668 Thousand ILS | 128.77% |
| 2016 Q4 | 668 Thousand ILS | 0.6% |
| 2015 FY | 292 Thousand ILS | 256.1% |
| 2015 Q2 | 611 Thousand ILS | 352.59% |
| 2015 Q1 | 135 Thousand ILS | 64.63% |
| 2015 Q4 | 292 Thousand ILS | -45.62% |
| 2015 Q3 | 537 Thousand ILS | -12.11% |
| 2014 Q3 | 200 Thousand ILS | 0.0% |
| 2014 FY | 82 Thousand ILS | -44.97% |
| 2014 Q4 | 82 Thousand ILS | -59.0% |
| 2013 Q3 | 403 Thousand ILS | 27.94% |
| 2013 Q1 | 365 Thousand ILS | 0.0% |
| 2013 FY | 149 Thousand ILS | -94.81% |
| 2013 Q2 | 315 Thousand ILS | -13.7% |
| 2013 Q4 | 149 Thousand ILS | -63.03% |
| 2012 FY | 2.87 Million ILS | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cannabotech LTD | 9.68 Million ILA | -349.365% |